In Vivo Retroviral Transduction of Cardiac Myofibroblasts Using Intramyocardial Injection Immediately Post-myocardial...

Area of Science:

• Cardiovascular Biology
• Gene Therapy
• Molecular Medicine

Background:

• Myocardial infarction (MI) leads to cell death and scar formation by extracellular matrix (ECM) deposition.
• Cardiac myofibroblasts produce ECM proteins and are key players in cardiac remodeling post-MI.
• Existing gene transfer methods into cardiac myofibroblasts are complex, costly, and time-consuming.

Purpose of the Study:

• To develop a novel, efficient, and cost-effective method for gene delivery into cardiac myofibroblasts.
• To overcome limitations of current gene transfer techniques in cardiac research.

Main Methods:

• Gene transfer into cardiac myofibroblasts using retroviruses generated from Plat-E packaging cells.
• Myocardial injection of retroviral solution directly into the infarct area of the left ventricle in mice post-coronary artery ligation.
• Utilized polybrene for enhanced viral transduction and a simple virus concentration method.

Main Results:

• Demonstrated successful gene introduction into myofibroblasts surrounding the MI site.
• Retroviral uptake is specific to proliferating cells, ensuring targeted gene transfer into myofibroblasts.
• Achieved long-term gene expression due to retroviral integration into the host genome.
• High infection efficiency in myofibroblasts was observed with myocardial injection targeting the infarct area.

Conclusions:

• The developed retroviral method provides a highly specific and efficient approach for gene transfer into cardiac myofibroblasts.
• This technique facilitates chronic in vivo evaluation of gene function in the context of myocardial infarction.
• The protocol is scalable, cost-effective, and simpler compared to existing methods.